JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hepner, D. L.
Right arrow Articles by Castells, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hepner, D. L.
Right arrow Articles by Castells, M. C.
Related Collections
Right arrow Complications
Right arrow Pharmacology

Anesth Analg 2003;97:1381-1395
© 2003 International Anesthesia Research Society

ANESTHETIC PHARMACOLOGY

Anaphylaxis During the Perioperative Period

David L. Hepner, MD*, and Mariana C. Castells, MD PhD{dagger}

*Department of Anesthesiology, Perioperative and Pain Medicine, and {dagger}Allergy and Clinical Immunology Training Program, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Address correspondence and reprint requests to David L. Hepner, MD, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115. Address e-mail to dhepner{at}partners.org

Anesthesiologists use a myriad of drugs during the provision of an anesthetic. Many of these drugs have side effects that are dose related, and some lead to severe immune-mediated adverse reactions. Anaphylaxis is the most severe immune-mediated reaction; it generally occurs on reexposure to a specific antigen and requires the release of proinflammatory mediators. Anaphylactoid reactions occur through a direct non-immunoglobulin E-mediated release of mediators from mast cells or from complement activation. Muscle relaxants and latex account for most cases of anaphylaxis during the perioperative period. Symptoms may include all organ systems and present with bronchospasm and cardiovascular collapse in the most severe cases. Management of anaphylaxis includes discontinuation of the presumptive drug (or latex) and anesthetic, aggressive pulmonary and cardiovascular support, and epinephrine. Although a serum tryptase confirms the diagnosis of an anaphylactic reaction, the offending drug can be identified by skinprick, intradermal testing, or serologic testing. Prevention of recurrences is critical to avoid mortality and morbidity.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
C. Schummer, M. Wirsing, and W. Schummer
The Pivotal Role of Vasopressin in Refractory Anaphylactic Shock
Anesth. Analg., August 1, 2008; 107(2): 620 - 624.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
W. Dietrich, A. Ebell, R. Busley, and A.-L. Boulesteix
Aprotinin and Anaphylaxis: Analysis of 12,403 Exposures to Aprotinin in Cardiac Surgery
Ann. Thorac. Surg., October 1, 2007; 84(4): 1144 - 1150.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
R. M. Ritchey, R. F. Helfand, S. A. Irefin, M. Argalious, and J. E. Tetzlaff
Hetastarch Allergy and Positive Latex Radioallergosorbent Test in a Patient Suffering Cardiovascular Decompensation During Multiple Perioperative Periods
Anesth. Analg., December 1, 2005; 101(6): 1709 - 1712.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M. E. McBrien, S. T. Webb, D. S. Breslin, A. D. Axon, and J. M. Hunter
Anaphylaxis and anaesthesia
Br. J. Anaesth., April 1, 2005; 94(4): 547 - 548.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. J. Russell
Anaphylaxis Is Not a Dose/Response Effect
Anesth. Analg., February 1, 2005; 100(2): 597 - 598.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
W. J. Russell
Cross-Reactivity Documented for Hemaccel and Gelofusin
Anesth. Analg., May 1, 2004; 98(5): 1499 - 1499.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. V. Roth and A. Shields
A Dilemma: How Does One Treat Anaphylaxis in the Sulfite Allergic Patient Since Epinephrine Contains Sodium Metabisulfite?
Anesth. Analg., May 1, 2004; 98(5): 1499 - 1499.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
D. S. Breslin, M. E. McBrien, and D. L. Hepner
Management of Severe Anaphylactic Reactions Should Include Administration of Alpha Adrenergic Agonists * Response
Anesth. Analg., May 1, 2004; 98(5): 1499 - 1500.
[Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2003 by the International Anesthesia Research Society.